Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Liabilities and Shareholders Equity (2021 - 2025)

Tenon Medical has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $10.8 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $10.8 million for Q4 2025, up 9.32% from a year ago — trailing twelve months through Dec 2025 was $45.6 million (up 23.64% YoY), and the annual figure for FY2025 was $10.8 million, up 9.32%.
  • Liabilities and Shareholders Equity for Q4 2025 was $10.8 million at Tenon Medical, up from $10.4 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for TNON hit a ceiling of $18.1 million in Q2 2022 and a floor of $6.0 million in Q2 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $9.9 million (2023), compared with a mean of $10.3 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 51.01% in 2023 and later skyrocketed 85.05% in 2025.
  • Tenon Medical's Liabilities and Shareholders Equity stood at $9.3 million in 2021, then increased by 19.6% to $11.1 million in 2022, then crashed by 42.78% to $6.3 million in 2023, then surged by 55.13% to $9.8 million in 2024, then grew by 9.32% to $10.8 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $10.8 million (Q4 2025), $10.4 million (Q3 2025), and $11.1 million (Q2 2025) per Business Quant data.